Fundraising Fox

Lexicon Pharmaceuticals

NASDAQ: LXRX

The Woodlands, US · Founded 1995 · Delaware corporation · 280 employees on LinkedIn · 1 known investors

Biotech

Founders & leadership

Lexicon Pharmaceuticals was founded in 1995 by Brian P. Zambrowicz.

BP
Brian P. ZambrowiczFounder
BT
Brian T. CrumExecutive
RM
Rachel MartensExecutive
SC
Scott CoianteExecutive
CB
Craig B. GranowitzExecutive
WE
Wendy E. McDermottExecutive
LD
Lisa DeFrancescoExecutive
AJ
Alan J. MainExecutive
PL
Pablo LapuertaExecutive
PT
Praveen TyleExecutive
JW
Jeffrey WadeExecutive
LC
Lonnel CoatsExecutive

Investors · 1

New Enterprise Associates (NEA)Menlo Park · $200K – $40M

Reported raises · per SEC filings

Form D private placements

$335.9M disclosed across 6 rounds · 2014–2026

▶$55.7MraisedFeb 2026 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Christopher SobeckiDirector
  • Judith L. SwainDirector
  • Raymond DebbaneDirector
  • Brian T. CrumExecutive Officer
  • Rachel MartensExecutive Officer
  • Scott CoianteExecutive Officer
  • Rachel MartensExecutive Officer
  • Samuel BarkerDirector
  • Craig B. GranowitzExecutive Officer
  • Ivan H. CheungDirector
  • Wendy E. McDermottExecutive Officer
  • Lisa DeFrancescoExecutive Officer
  • Phillipe J. AmouyalDirector
  • Suma GopinathanExecutive Officer
  • Mike ExtonExecutive Officer, Director
  • Diane SullivanDirector
Offering amount
$59.1M
Amount sold
$55.7M
First sale
Feb 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$72.2MraisedJun 2023 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Phillipe J. AmouyalDirector
  • Kenneth Kassler-TaubExecutive Officer
  • Alan J. MainExecutive Officer
  • Jeffrey WadeExecutive Officer
  • Samuel BarkerDirector
  • Christopher J. SobeckiDirector
  • Craig B. GranowitzExecutive Officer
  • Brian T. CrumExecutive Officer
  • Alan S. NiesDirector
  • Frank P. PalantoniDirector
  • Raymond DebbaneDirector
  • Kristen L. AlexanderExecutive Officer
  • Robert LefkowitzDirector
  • Judith L. SwainDirector
  • Wendy E. McDermottExecutive Officer
  • Lonnel CoatsExecutive Officer, Director
Offering amount
$72.2M
Amount sold
$72.2M
First sale
Jun 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$42.9MraisedAug 2022 · 2 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Phillipe J. AmouyalDirector
  • Judith L. SwainDirector
  • Jeffrey WadeExecutive Officer
  • Robert J. LefkowitzDirector
  • Alan J. MainExecutive Officer
  • Raymond DebbaneDirector
  • Christopher J. SobeckiDirector
  • Brian T. CrumExecutive Officer
  • Alan S. NiesDirector
  • Kiernan A. SethExecutive Officer
  • Craig B. GranowitzExecutive Officer
  • Lonnel CoatsExecutive Officer, Director
  • Kristen L. AlexanderExecutive Officer
  • Kenneth Kassler-TaubExecutive Officer
  • Frank P. PalantoniDirector
  • Samuel L. BarkerDirector
  • Wendy E. McDermottExecutive Officer
Offering amount
$49.3M
Amount sold
$42.9M
First sale
Aug 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10.5MraisedMar 2017 · 16 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Alan S. NiesDirector
  • Alan J. MainExecutive Officer
  • Pablo LapuertaExecutive Officer
  • Philippe J. AmouyalDirector
  • Frank P. PalantoniDirector
  • Robert J. LefkowitzDirector
  • Christopher J. SobeckiDirector
  • Praveen TyleExecutive Officer
  • Judith L. SwainDirector
  • Jeffrey L. WadeExecutive Officer
  • Raymond DebbaneDirector
  • Lonnel CoatsExecutive Officer, Director
  • Alexander SantiniExecutive Officer
  • James F. TessmerExecutive Officer
  • Samuel L. BarkerDirector
Offering amount
$10.5M
Amount sold
$10.5M
First sale
Mar 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.7MraisedDec 2014 · 16 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Alan S. NiesDirector
  • Robert J. LefkowitzDirector
  • Jeffrey L. WadeExecutive Officer
  • Raymond DebbaneDirector
  • Christopher J. SobeckiDirector
  • John NorthcottExecutive Officer
  • Frank P. PalantoniDirector
  • Lonnel CoatsExecutive Officer, Director
  • Philippe J. AmouyalDirector
  • Brian P. ZambrowiczExecutive Officer
  • James F. TessmerExecutive Officer
  • Judith L. SwainDirector
  • Samuel L. BarkerDirector
  • Alan J. MainExecutive Officer
  • Pablo LapuertaExecutive Officer
Offering amount
$4.7M
Amount sold
$4.7M
First sale
Dec 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$150MraisedDec 2014 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey L. WadeExecutive Officer
  • Pablo LapuertaExecutive Officer
  • Judith L. SwainDirector
  • Philippe J. AmouyalDirector
  • Christopher J. SobeckiDirector
  • Brian P. ZambrowiczExecutive Officer
  • Robert J. LefkowitzDirector
  • Alan J. MainExecutive Officer
  • James F. TessmerExecutive Officer
  • Samuel L. BarkerDirector
  • John NorthcottExecutive Officer
  • Alan S. NiesDirector
  • Frank P. PalantoniDirector
  • Lonnel CoatsExecutive Officer, Director
  • Raymond DebbaneDirector
Offering amount
$150M
Amount sold
$150M
First sale
Nov 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who founded Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals was founded by Brian P. Zambrowicz in 1995.
Who are Lexicon Pharmaceuticals's investors?
Lexicon Pharmaceuticals's investors include New Enterprise Associates (NEA).
How much funding has Lexicon Pharmaceuticals raised?
Lexicon Pharmaceuticals has disclosed $335.9M raised across 6 rounds.
Where is Lexicon Pharmaceuticals headquartered?
Lexicon Pharmaceuticals is headquartered in The Woodlands, US.